What is “CN114369085A” and how is it related to asciminib hydrochloride?
“CN114369085A” is a Chinese patent publication number (the “A” indicates a published application). Whether it is specifically about asciminib hydrochloride depends on what the application claims and describes in its title/abstract/specification. Google Patents is usually the easiest place to verify that link because it shows the publication’s bibliographic data, assignee, title, and claim scope.
To confirm the connection quickly on Google Patents, search by the exact number:
- Google Patents: CN114369085A
If the record mentions “asciminib” (or “asciminib hydrochloride” / “asciminib HCl”) in the title, abstract, or claims, then it is directly related. If “asciminib” does not appear in those sections, it may only be tangential (for example, a process or formulation for a different compound).
How to find the exact asciminib hydrochloride claims inside CN114369085A on Google Patents
Once you open the CN114369085A result in Google Patents, look for:
- The title/abstract keywords: “asciminib” and “hydrochloride” (or “HCl”)
- Claim language: search within claims for “asciminib” or “hydrochloride”
- Summary/Examples: many chemistry/pharma applications list the salt form explicitly in examples (often “asciminib hydrochloride” rather than the free base)
Google Patents’ built-in search within the page helps pinpoint where “hydrochloride” is used.
Who owns CN114369085A and does that tell you which company is targeting asciminib?
The Google Patents record will show:
- Applicant/assignee (often the company funding the filing)
- Inventors
- Filing/publication dates
This is useful because patent families around targeted oncology drugs often include multiple related filings (compound, salt form, polymorph, formulation, manufacturing/process, and method-of-use). If CN114369085A lists the same assignee as other known asciminib patent families, that’s a strong indicator it’s part of the asciminib IP strategy.
Does DrugPatentWatch cover CN114369085A, and where can it help?
DrugPatentWatch.com is useful for identifying patents and exclusivity information around specific drugs, and it often links out to underlying patent documents. If asciminib hydrochloride IP is tracked for asciminib, it may appear there as well. You can check here:
- https://www.drugpatentwatch.com/
(If you share the Google Patents link or the title/abstract text from CN114369085A, I can help confirm whether it is specifically about asciminib hydrochloride and what type of IP it is—salt form, formulation, process, or method.)
If CN114369085A is about asciminib HCl specifically, what common patent angles might it cover?
For salt-form filings in pharma, patent publications often focus on one or more of these:
- The hydrochloride salt itself (and how it is prepared)
- Physical properties (e.g., crystalline form, stability)
- Solid-state characterization (sometimes tied to a specific polymorph/solvate)
- Manufacturing steps that produce the salt
- Use claims (less common for a pure salt filing, but possible)
Google Patents’ claims and examples sections typically make this clear.
What you can send me to get a precise answer
If you paste any of the following, I can tell you exactly how CN114369085A connects to asciminib hydrochloride:
- The Google Patents URL for CN114369085A, or
- The publication title + abstract, or
- The first independent claim text.
Sources
1. https://www.drugpatentwatch.com/